OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...

The NHS is urging thousands of people to cut down on their intake of tea and coffee due to an uncomfortable side effect ...

Phase 1 healthy volunteer trial ongoing, complete SAD/MAD data expected in June 2025KT-621 Phase 1b trial in atopic dermatitis ...

Thousands of people in the UK who take the medication are being encouraged to make the diet change to avoid side effects ...

Q4 2024 Earnings Call Transcript February 27, 2025 Ligand Pharmaceuticals Incorporated misses on earnings expectations.

Astrana Health, Inc. ( NASDAQ: ASTH) Q4 2024 Earnings Conference Call February 27, 2025 5:30 PM ET Brandon Sim - President & CEO Chan Basho - Chief Operating & Financial Officer ...

US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238.6 million in FY 2024, up 10% and 8%, respectively ...

When the sedatives and antidepressants prescribed for PTSD don't work, some veterans have found peace through psychedelics.

Osteopathy is non-invasive manual therapy targeting the joints, muscles, and spine. It is a form of physical therapy that seeks to improve ...

The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...